Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

• Status: Terminated
• Trial end date: 2002-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Studies of PEG-paclitaxel have been terminated

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Enzon Pharmaceuticals, Inc.
• Treatments: Albumin-Bound Paclitaxel; Paclitaxel

Criteria

None - Study has been terminated.